Disc Medicine Lands Million: Investors React to FDA Catalyst
A private equity firm just disclosed a sizable stake in Disc Medicine, signaling growing confidence in its red blood ...
Using historical data can significantly enhance your ability to choose index funds. Learn how to leverage this information for better investments.
26,191 articlesA private equity firm just disclosed a sizable stake in Disc Medicine, signaling growing confidence in its red blood ...
A new, concentrated fund is delivering outsized tech gains fueled by Nvidia, Micron and TSMC. The fund’s early-2026 s...
NVIDIA's CEO hints that the next wave of wealth could come from skilled trades like plumbing and electrical work, pro...
The AI inference market could surge to about $255 billion by 2030 as demand for real-time AI services climbs. Learn w...
A major fund’s exit from Ocular Therapeutix raises questions about timing, liquidity, and sector signals. This articl...
A new Fed chair angles for a disciplined inflation fight and a leaner balance sheet, even as markets seek clarity. He...
As GoodRx navigates evolving discount dynamics and a changing membership model, the 2025 earnings picture will hinge ...
Analysts weigh the implications of a hypothetical kevin warsh sworn federal chair scenario. Markets could reprice pol...
May 2026 hands investors a surprise: a big jump in M2 money supply could rekindle inflation pressures. Markets weigh ...
When insiders trade, investors pay attention. This article breaks down what seacoast banking corp. sells signals, how...
Elon Musk’s clash with OpenAI doubles as a bid to launch xAI, with Tesla financing and strategic partnerships setting...
France faces a sharp rise in crypto related abductions, forcing authorities to trace the personal data criminals expl...